Trudiagnostic

CLIA Laboratory Citation Details

2
Total Citations
10
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 18D2183496
Address 881 Corporate Drive, Lexington, KY, 40503
City Lexington
State KY
Zip Code40503
Phone(888) 909-3634

Citation History (2 surveys)

Survey - April 30, 2024

Survey Type: Complaint

Survey Event ID: SJTZ11

Deficiency Tags: D6076 D6078 D6078 D0000 D0000 D6076

Summary:

Summary Statement of Deficiencies D0000 An abbreviated survey investigating Complaint KY00042353 was conducted on 04/30 /2024. The facility was found not to be in compliance with the laboratory requirements of 42 CFR Part 493 with deficiencies cited. D6076 LABORATORY DIRECTOR CFR(s): 493.1441 The laboratory must have a director who meets the qualification requirements of 493. 1443 of this subpart and provides overall management and direction in accordance with 493.1445 of this subpart. This CONDITION is not met as evidenced by: Based on facility document review, policy review, and confirmed in staff interview, the laboratory failed to ensure that 1 of 1 individuals reviewed had the board certification to serve as a high complexity Laboratory Director (LD). Refer to D6078. D6078 LABORATORY DIRECTOR QUALIFICATIONS CFR(s): 493.1443 The laboratory director must be qualified to manage and direct the laboratory personnel and performance of high complexity tests and must be eligible to be an operator of a laboratory within the requirements of subpart R. (a) The laboratory director must possess a current license as a laboratory director issued by the State in which the laboratory is located, if such licensing is required; and (b) The laboratory director must-- (b)(1)(i) Be a doctor of medicine or doctor of osteopathy licensed to practice medicine or osteopathy in the State in which the laboratory is located; and (b) (1)(ii) Be certified in anatomic or clinical pathology, or both, by the American Board of Pathology or the American Osteopathic Board of Pathology or possess qualifications that are equivalent to those required for such certification; or (b)(2) Be a doctor of medicine, a doctor of osteopathy or doctor of podiatric medicine licensed to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- practice medicine, osteopathy or podiatry in the State in which the laboratory is located; and (b)(2)(i) Have at least one year of laboratory training during medical residency (for example, physicians certified either in hematology or hematology and medical oncology by the American Board of Internal Medicine); or (b)(2)(ii) Have at least 2 years of experience directing or supervising high complexity testing; or (b)(3) Hold an earned doctoral degree in a chemical, physical, biological or clinical laboratory science from an accredited institution and-- (b)(3)(i) Be certified and continue to be certified by a board approved by HHS; or (b)(3)(ii) Before February 24, 2003, must have served or be serving as director of a laboratory performing high complexity testing and must have at least-- (b)(3)(ii)(A) Two years of laboratory training or experience, or both; and (b)(3)(ii)(B) Two years of laboratory experience directing or supervising high complexity testing. (b)(4) Be serving as a laboratory director and must have previously qualified or could have qualified as a laboratory director under regulations at 42 CFR 493.1415, published March 14, 1990 at 55 FR 9538, on or before February 28, 1992; or (b)(5) On or before February 28, 1992, be qualified under State law to direct a laboratory in the State in which the laboratory is located; or (b)(6) For the subspecialty of oral pathology, be certified by the American Board of Oral Pathology, American Board of Pathology, the American Osteopathic Board of Pathology, or possess qualifications that are equivalent to those required for certification. This STANDARD is not met as evidenced by: Based on review of laboratory policy, review of Centers for Medicare and Medicaid (CMS) forms, review of laboratory documents, and confirmed in staff interview, the laboratory failed to ensure that 1 of 1 individuals reviewed met the regulatory requirements to serve as the Laboratory Director (LD) for high complexity testing. Findings included: Review of a laboratory policy titled, "Laboratory Director Responsibilities and Duties Including Delegation," developed on 01/06/2022 by the LD, revealed "The Laboratory Director is responsible for the overall operation and administration of the laboratory, including provision of timely, reliable and clinically relevant test results and compliance with applicable regulations and accreditation requirements." Review of the CMS "Clinical Laboratory Improvement Amendments (CLIA) Application for Certification" form, dated 04/30/2024, revealed the LD was listed as the laboratory's LD. Review of the CMS "Laboratory Personnel Report (CLIA)" form, dated 04/30/2024, revealed the LD was listed as the laboratory's LD. Review of the "Laboratory Director Responsibilities and Duties Including Delegation Forms," signed and dated by the LD on 11/15/2022, revealed all listed duties were delegated to the Technical Supervisor/General Supervisor (TS/GS). Those duties included technical and scientific oversight, method validation/verification studies, proficiency testing, quality control and quality management, monthly quality control /quality management review, remedial/

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 2, 2023

Survey Type: Standard

Survey Event ID: B8TJ11

Deficiency Tags: D0000 D5217 D0000 D5217

Summary:

Summary Statement of Deficiencies D0000 A recertification survey was conducted on 02/02/2023 and the facility was found not to be in substantial compliance with the laboratory requirements at 42 CFR Part 493, with deficiencies cited. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on record review and interview with the Technical Supervisor (TS), the laboratory failed to twice annually verify the accuracy of epigenetic-methylation deoxyribonucleic acid (DNA) testing for two (2) of two (2) years reviewed (2021 and 2022). The findings include: Review of laboratory records revealed accuracy verification was performed once for 2021, on 01/07/2021, and once for 2022, on 07/25 /2022. Accuracy verification was not performed a second time as required for 2021 or 2022. Interview with the TS, on 02/02/2023 at 1:18 PM, revealed that accuracy verification was performed by giving five (5) samples to personnel for testing and comparing results to known values. The TS stated that the verification should be performed twice per year, but it was not consistent. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access